Sculptor Capital’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Sculptor Capital’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,944	Closed	-$239K	–	1186
2022 Q3	$239K	Buy	23,944 +1,256	+6%	+$12.5K	﹤0.01%	658
2022 Q2	$224K	Buy	22,688 +9,294	+69%	+$91.7K	﹤0.01%	727
2022 Q1	$131K	Buy	+13,394	New	+$131K	﹤0.01%	900

Sculptor Capital's FLAC Position: Q4 2022 in Review

Sculptor Capital sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 23,944 shares — an estimated $239K sold.

Sculptor Capital first reported a position in FLAC in Q1 2022 and held it in 3 quarters. The position peaked at $239K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Sculptor Capital reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Sculptor Capital sold 23,944 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $239K.
Sculptor Capital first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2022 and held it in 3 quarters.
Sculptor Capital's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $239K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Sculptor Capital's 13F filing for Q4 2022, filed 14 Feb 2023.